AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pacira BioSciences, Inc. Director's Dealing 2016

Jun 9, 2016

32125_dirs_2016-06-08_13640860-d28b-4702-8199-041a85e553c5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2016-06-06

Reporting Person: Riker Lauren Bullaro (Vice President, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-06	Common Stock	S	321	$47.199	Disposed	5945	Direct
2016-06-07	Common Stock	S	100	$47.898	Disposed	5845	Direct
2016-06-07	Common Stock	S	517	$47.902	Disposed	5328	Direct

Footnotes

F1: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2: Includes 232 shares and 54 shares of common stock acquired under the issuer's employee stock purchase plan in June 2015 and December 2015, respectively.